| 000 | 01854 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516211101.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1569-9285 | ||
| 024 | 7 |
_a10.1093/icvts/ivu114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRessia, Laura | |
| 245 | 0 | 0 |
_aBeneficial effect of fenoldopam mesylate in preventing peak blood lactate level during cardiopulmonary bypass for paediatric cardiac surgery. _h[electronic resource] |
| 260 |
_bInteractive cardiovascular and thoracic surgery _cAug 2014 |
||
| 300 |
_a178-82 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAcidosis, Lactic _xblood |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiac Surgical Procedures _xadverse effects |
| 650 | 0 | 4 |
_aCardiopulmonary Bypass _xadverse effects |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDopamine Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aElective Surgical Procedures |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenoldopam _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 |
_aLactic Acid _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOperative Time |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVasodilator Agents _xadministration & dosage |
| 700 | 1 | _aCalevo, Maria Grazia | |
| 700 | 1 | _aLerzo, Franco | |
| 700 | 1 | _aCarleo, Anna Maria | |
| 700 | 1 | _aPetrucci, Lara | |
| 700 | 1 | _aMontobbio, Giovanni | |
| 773 | 0 |
_tInteractive cardiovascular and thoracic surgery _gvol. 19 _gno. 2 _gp. 178-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/icvts/ivu114 _zAvailable from publisher's website |
| 999 |
_c23773753 _d23773753 |
||